Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines-Reference-Cited by-同舟云学术

Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines

Published:2012-04 Issue:4 Volume:56 Page:886-892
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Takayasu Kenichi,Arii Shigeki,Kudo Masatoshi,Ichida Takafumi,Matsui Osamu,Izumi Namiki,Matsuyama Yutaka,Sakamoto Michiie,Nakashima Osamu,Ku Yonson,Kokudo Norihiro,Makuuchi Masatoshi

Publisher

Elsevier BV

Subject

Hepatology

Reference14 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Prognostic prediction and treatment strategy in hepatocellular carcinoma;Bruix;Hepatology,2002

3. Report of the 18th follow up survey of primary liver cancer in Japan;Ikai;Hepatol Res,2010

4. Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization;Matsui;Radiology,1993

5. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver;Bruix;J Hepatol,2001

Cited by 191 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Outcomes of Use of the Porous Glass Membrane Pumping Emulsification Device During Transarterial Chemoembolization for Hepatocellular Carcinoma;Anticancer Research;2024-06-26

2. Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study;eClinicalMedicine;2024-06

3. Multidisciplinary Treatment of Hepatocellular Carcinoma in 2023: Italian practice Treatment Guidelines of the Italian Association for the Study of the Liver (AISF), Italian Association of Medical Oncology (AIOM), Italian Association of Hepato-Bilio-Pancreatic Surgery (AICEP), Italian Association of Hospital Gastroenterologists (AIGO), Italian Association of Radiology and Clinical Oncology (AIRO), Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP), Italian Society of Surgery (SIC), Italian Society of Gastroenterology (SIGE), Italian Society of Medical and Interventional Radiology (SIRM), Italian Organ Transplant Society (SITO), and Association of Patients with Hepatitis and Liver Disease (EpaC) – Part I – Surgical treatments;Digestive and Liver Disease;2024-02

4. Screening, Surveillance, and Prevention of Hepatocellular Carcinoma;Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e;2024-01-23

5. Predictors for early recurrence beyond up-to-7 or distant metastasis after hepatocellular carcinoma resection: proposal for borderline resectable HCC;International Journal of Clinical Oncology;2024-01-16